Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer†

Abstract

OBJECTIVES Large retrospective series have indicated lower rates of cN0 to pN1 nodal upstaging after video-assisted thoracic surgery (VATS) compared with open resections for Stage I non-small-cell lung cancer (NSCLC). The objective of our multicentre study was to investigate whether the presumed lower rate of N1 upstaging after VATS disappears after correction for central tumour location in a multivariable analysis. METHODS Consecutive patients operated for PET-CT based clinical Stage I NSCLC were selected from prospectively managed surgical databases in 11 European centres. Central tumour location was defined as contact with bronchovascular structures on computer tomography and/or visibility on standard bronchoscopy. RESULTS Eight hundred and ninety-five patients underwent pulmonary resection by VATS (n = 699, 9% conversions) or an open technique (n = 196) in 2014. Incidence of nodal pN1 and pN2 upstaging was 8% and 7% after VATS and 15% and 6% after open surgery, respectively. pN1 was found in 27% of patients with central tumours. Less central tumours were operated on by VATS compared with the open technique (12% vs 28%, P < 0.001). Logistic regression analysis showed that only tumour location had a significant impact on N1 upstaging (OR 6.2, confidence interval 3.6–10.8; P < 0.001) and that the effect of surgical technique (VATS versus open surgery) was no longer significant when accounting for tumour location. CONCLUSIONS A quarter of patients with central clinical Stage I NSCLC was upstaged to pN1 at resection. Central tumour location was the only independent factor associated with N1 upstaging, undermining the evidence for lower N1 upstaging after VATS resections. Studies investigating N1 upstaging after VATS compared with open surgery should be interpreted with caution due to possible selection bias, i.e. relatively more central tumours in the open group with a higher chance of N1 upstaging.

Comparison of Video-assisted Thoracoscopic Lobectomy versus Open Thoracotomy for Primary Non Small Cell Lung Cancer - 269 Cases Single Cohort Study

“…[9] Experienced centers perform VATS resections in tumors greater than 3 cm and locally advanced NSCLC with success. [10] Pischik et al [11] determined a cut point of greater than 5 cm of tumor size to define a locally extensive for VATS cases in 2014.…”

Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA): Recipe and Cooking Secrets (a Tutorial)

“…We have to bring 2 aspects to mind: (1) the ancient but still present definition of an N3-status meaning surgically not accessible and (2) it is becoming increasingly clear that the percentage of positive lymph nodes (the so called "node ratio") depict the clinically relevant tumor stadium more accurate than the anatomical N2/3 categorization. [14][15][16][17][18][19][20] Both keynotes will be translated into the upcoming 9th edition of the Union for International Cancer Control staging system for lung cancer-as well as being basis for ongoing research as clinical investigators increasingly lift out the lively character of a tumor instead of its strict compartmentation. So after more than 60 years of great facility and constant advancements the golden age of up-to-date mediastinoscopy-which is called VAMLA for nearly 20 years-is not over for a long time yet.…”

Risk of recurrence in stage I adenocarcinoma of the lung: a multi-institutional study on synergism between type of surgery and type of nodal staging

“…However, new minimally invasive biopsy techniques (15,16) and high definition imaging rise doubts on unavoidability of such aggressive nodal assessment. Nevertheless, several studies reported an unexpected high occurrence of a node-positive occult disease in primary and secondary lung tumors (36)(37)(38)(39) probably due to microscopic lymph nodal involvement. Contrariwise, this happened in less than 4% of cases ACOSOG Z0030 trial (23); in this study, systematic nodal dissection showed no survival benefit of over nodal sampling (NS).…”